David MF - Search Results

1

Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis.

Samuel D, Zignego AL, Reynes M, Feray C, Arulnaden JL, David MF, Gigou M, Bismuth A, Mathieu D, Gentilini P, et al. Samuel D, et al. Among authors: david mf. Hepatology. 1995 Feb;21(2):333-9. Hepatology. 1995. PMID: 7843702

2

[Relapse prevention in liver transplant patients treated for liver involvement due to hepatitis B virus].

Bismuth A, Arulnaden JL, Samuel D, David MF, Pichon F, Mathieu D, Farahmand H, Farrokhi P, Feray C, Brechot C, et al. Bismuth A, et al. Among authors: david mf. Rev Fr Transfus Hemobiol. 1992 Mar;35(2):107-23. doi: 10.1016/s1140-4639(05)80111-x. Rev Fr Transfus Hemobiol. 1992. PMID: 1637419 French.

3

An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection.

Féray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, Reynès M, Bismuth H. Féray C, et al. Among authors: david mf. Hepatology. 1995 Oct;22(4 Pt 1):1084-9. Hepatology. 1995. PMID: 7557855 Clinical Trial.

4

The course of hepatitis C virus infection after liver transplantation.

Féray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Urdea M, Reynes M, Bréchot C, Bismuth H. Féray C, et al. Among authors: david mf. Hepatology. 1994 Nov;20(5):1137-43. doi: 10.1002/hep.1840200506. Hepatology. 1994. PMID: 7927244

5

Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease.

Marcellin P, Samuel D, Areias J, Loriot MA, Arulnaden JL, Gigou M, David MF, Bismuth A, Reynes M, Bréchot C, et al. Marcellin P, et al. Among authors: david mf. Hepatology. 1994 Jan;19(1):6-12. Hepatology. 1994. PMID: 8276368

6

De novo and apparent de novo hepatitis B virus infection after liver transplantation.

Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, David MF, Arulnaden JL, Bismuth A, Reynes M, Bismuth H. Roche B, et al. Among authors: david mf. J Hepatol. 1997 Mar;26(3):517-26. doi: 10.1016/s0168-8278(97)80416-3. J Hepatol. 1997. PMID: 9075658

7

Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation.

Roche B, Samuel D, Gigou M, Feray C, Virot V, Majno P, Serraf L, David MF, Dusseaix E, Reynes M, Bismuth H. Roche B, et al. Among authors: david mf. J Hepatol. 1999 Oct;31(4):584-92. doi: 10.1016/s0168-8278(99)80335-3. J Hepatol. 1999. PMID: 10551379

8

Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients.

Saliba F, Eyraud D, Samuel D, David MF, Arulnaden JL, Dussaix E, Mathieu D, Bismuth H. Saliba F, et al. Among authors: david mf. Transplant Proc. 1993 Feb;25(1 Pt 2):1444-5. Transplant Proc. 1993. PMID: 8382876 Clinical Trial. No abstract available.

9

Factors associated with survival in human immunodeficiency virus-positive patients and disseminated Mycobacterium avium complex infection.

Miailhes P, Cot M, Mathieu D, David MF, Vincent V, Vittecoq D. Miailhes P, et al. Among authors: david mf. Clin Microbiol Infect. 1999 Jul;5(7):431-436. doi: 10.1111/j.1469-0691.1999.tb00167.x. Clin Microbiol Infect. 1999. PMID: 11853568 Free article. No abstract available.

10

Wood ash decreases cadmium toxicity to the soil nematode Caenorhabditis elegans.

Johansen JL, David MF, Ekelund F, Vestergård M. Johansen JL, et al. Among authors: david mf. Ecotoxicol Environ Saf. 2019 May 15;172:290-295. doi: 10.1016/j.ecoenv.2019.01.092. Epub 2019 Feb 1. Ecotoxicol Environ Saf. 2019. PMID: 30716663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters